HRP20181033T1 - Postupak za odabir sredstava koja djeluju na poremećaj pokretljivosti crijeva i bol - Google Patents

Postupak za odabir sredstava koja djeluju na poremećaj pokretljivosti crijeva i bol Download PDF

Info

Publication number
HRP20181033T1
HRP20181033T1 HRP20181033TT HRP20181033T HRP20181033T1 HR P20181033 T1 HRP20181033 T1 HR P20181033T1 HR P20181033T T HRP20181033T T HR P20181033TT HR P20181033 T HRP20181033 T HR P20181033T HR P20181033 T1 HRP20181033 T1 HR P20181033T1
Authority
HR
Croatia
Prior art keywords
agent
reduce
ability
mmc
gastrointestinal
Prior art date
Application number
HRP20181033TT
Other languages
English (en)
Croatian (hr)
Inventor
Eamonn Connolly
Wolfgang Kunze
John Bienenstock
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49115523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20181033(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of HRP20181033T1 publication Critical patent/HRP20181033T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/10—Segmentation; Edge detection
    • G06T7/13—Edge detection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30092—Stomach; Gastric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Quality & Reliability (AREA)
  • Toxicology (AREA)
  • Radiology & Medical Imaging (AREA)
HRP20181033TT 2012-09-03 2013-09-03 Postupak za odabir sredstava koja djeluju na poremećaj pokretljivosti crijeva i bol HRP20181033T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261696277P 2012-09-03 2012-09-03
PCT/EP2013/068202 WO2014033330A1 (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain
EP13756897.8A EP2893045B1 (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Publications (1)

Publication Number Publication Date
HRP20181033T1 true HRP20181033T1 (hr) 2018-08-24

Family

ID=49115523

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181033TT HRP20181033T1 (hr) 2012-09-03 2013-09-03 Postupak za odabir sredstava koja djeluju na poremećaj pokretljivosti crijeva i bol

Country Status (27)

Country Link
US (5) US9555065B2 (enExample)
EP (2) EP3369808A1 (enExample)
JP (3) JP6259458B2 (enExample)
KR (1) KR102293438B1 (enExample)
CN (4) CN108904545A (enExample)
AU (1) AU2013308299B2 (enExample)
CA (2) CA3268968A1 (enExample)
CL (2) CL2015000490A1 (enExample)
CO (1) CO7350654A2 (enExample)
DK (1) DK2893045T3 (enExample)
ES (1) ES2681974T3 (enExample)
GE (1) GEP201706775B (enExample)
HK (1) HK1258778A1 (enExample)
HR (1) HRP20181033T1 (enExample)
IL (2) IL237397B (enExample)
IN (1) IN2015DN01572A (enExample)
LT (1) LT2893045T (enExample)
MX (2) MX362495B (enExample)
MY (2) MY195532A (enExample)
NZ (1) NZ705358A (enExample)
PH (1) PH12015500452B1 (enExample)
RU (1) RU2701348C2 (enExample)
SG (3) SG10201608055XA (enExample)
SI (1) SI2893045T1 (enExample)
UA (2) UA118339C2 (enExample)
WO (1) WO2014033330A1 (enExample)
ZA (1) ZA201501472B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013002667B1 (pt) 2010-08-04 2020-02-04 Thomas Julius Borody composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las
CN108094541A (zh) * 2018-01-11 2018-06-01 黑龙江完达山林海液奶有限公司 一种具有保健益生功能的风味发酵乳及其制备方法
CN117487686A (zh) * 2018-07-24 2024-02-02 生命大地女神有限公司 选择和使用褪黑素支持细菌以减少婴儿绞痛
WO2020247568A1 (en) * 2019-06-05 2020-12-10 Avl Powertrain Engineering, Inc. Vehicle axle assembly
EP3980285A1 (en) 2019-06-05 2022-04-13 AVL Powertrain Engineering, Inc. Vehicle frame assembly and power supply tray
US12263752B2 (en) 2019-06-05 2025-04-01 Avl Mobility Technologies, Inc. Vehicle frame and power supply assembly and related systems and methods
CN110186922B (zh) * 2019-06-25 2021-07-23 西安交通大学医学院第一附属医院 一种监测结肠移行性复合运动的实验装置及方法
US11843097B2 (en) 2019-09-10 2023-12-12 Avl Powertrain Engineering, Inc. Power supply control systems and methods
CN112710823B (zh) * 2020-12-17 2024-03-29 中国科学院深圳先进技术研究院 一种肠移行性复合运动的离体检测系统及其应用
CN114342878B (zh) * 2022-01-10 2022-09-30 南京鼓楼医院 一种慢传输型便秘动物模型的建立方法
CN117384804A (zh) * 2023-12-12 2024-01-12 北京三元食品股份有限公司 格氏乳杆菌b1-26及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438989A (en) * 1990-08-10 1995-08-08 Hochman; Darryl Solid tumor, cortical function, and nerve tissue imaging methods and device
TR200100361T2 (tr) * 1998-08-21 2001-06-21 Novartis Ag Yeni oral formülasyon
CZ200213A3 (cs) * 1999-07-06 2002-08-14 Enpharma L. P. Prostředky k regulaci motility zaľívací soustavy a přijímání potravy
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
US20090233888A1 (en) * 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
JP5036020B2 (ja) * 2005-11-30 2012-09-26 雪印メグミルク株式会社 腎周囲脂肪蓄積抑制剤
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
JP5019563B2 (ja) * 2006-06-16 2012-09-05 旭化成ケミカルズ株式会社 腸内細菌賦活剤
US9254275B2 (en) * 2007-09-17 2016-02-09 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
SG177541A1 (en) * 2009-07-31 2012-02-28 Nestec Sa Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
US20110110905A1 (en) * 2009-11-06 2011-05-12 Ritchie Jennifer A Infant Colic Supplement
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20120034198A1 (en) * 2010-08-04 2012-02-09 Microbios, Inc. Carriers for storage and delivery of biologics
CN102304489B (zh) * 2011-09-23 2013-06-12 北京龙科方舟生物工程技术有限公司 一株罗伊氏乳杆菌及其应用

Also Published As

Publication number Publication date
AU2013308299A1 (en) 2015-03-26
EP3369808A1 (en) 2018-09-05
JP6259458B2 (ja) 2018-01-10
CN108904545A (zh) 2018-11-30
SG11201501297TA (en) 2015-03-30
PH12015500452A1 (en) 2015-04-20
SG10201608055XA (en) 2016-11-29
RU2015112102A (ru) 2016-10-20
MY195532A (en) 2023-01-31
US20170114422A1 (en) 2017-04-27
HK1258774A1 (zh) 2019-11-22
CN108753645A (zh) 2018-11-06
US20220306984A1 (en) 2022-09-29
MX362495B (es) 2019-01-21
AU2013308299B2 (en) 2019-04-18
IN2015DN01572A (enExample) 2015-07-03
CO7350654A2 (es) 2015-08-10
HK1211848A1 (en) 2016-06-03
GEP201706775B (en) 2017-11-27
RU2701348C2 (ru) 2019-09-26
JP2018090616A (ja) 2018-06-14
NZ705358A (en) 2018-09-28
JP2018029588A (ja) 2018-03-01
US20190112676A1 (en) 2019-04-18
MY182358A (en) 2021-01-20
CA3268968A1 (en) 2025-11-29
PH12015500452B1 (en) 2023-01-20
KR20150048201A (ko) 2015-05-06
HK1258778A1 (zh) 2019-11-22
IL259652B (en) 2020-03-31
UA126374C2 (uk) 2022-09-28
CA2883440A1 (en) 2014-03-06
CN108753645B (zh) 2019-10-22
CN104918640A (zh) 2015-09-16
JP2015529329A (ja) 2015-10-05
ES2681974T3 (es) 2018-09-17
KR102293438B1 (ko) 2021-08-25
CL2015000490A1 (es) 2015-05-29
US9555065B2 (en) 2017-01-31
CN104918640B (zh) 2019-03-19
DK2893045T3 (en) 2018-07-30
LT2893045T (lt) 2018-07-25
ZA201501472B (en) 2016-06-29
US9816150B2 (en) 2017-11-14
IL259652A (en) 2018-07-31
SG10202101556WA (en) 2021-03-30
IL237397B (en) 2018-10-31
US20180023150A1 (en) 2018-01-25
MX2015002792A (es) 2015-05-07
JP6476328B2 (ja) 2019-02-27
US20150231186A1 (en) 2015-08-20
CL2017002826A1 (es) 2018-04-06
MX2018013097A (es) 2020-09-02
EP2893045B1 (en) 2018-05-16
UA118339C2 (uk) 2019-01-10
CN109966511A (zh) 2019-07-05
JP6322326B2 (ja) 2018-05-09
EP2893045A1 (en) 2015-07-15
US10174388B2 (en) 2019-01-08
IL237397A0 (en) 2015-04-30
SI2893045T1 (en) 2018-08-31
WO2014033330A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
HRP20181033T1 (hr) Postupak za odabir sredstava koja djeluju na poremećaj pokretljivosti crijeva i bol
Gadaleta et al. Bile salt hydrolase-competent probiotics in the management of IBD: unlocking the “bile acid code”
JP2015529329A5 (enExample)
SG11202001067WA (en) Distributed ledger based system and method for the settlement and transfer of title to real estate
Hatziioanou et al. A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance
EP3830127A4 (en) Muscle targeting complexes and uses thereof for treating pompe disease
EP3624446C0 (en) METHOD FOR TRANSMITTING/RECEIVING 360-DEGREE VIDEO COMPRISING ULTRA-WIDE ANGLE TYPE VIDEO INFORMATION, AND RELATED DEVICE
SG11202002606UA (en) Method and system for geometrical reconstruction of an internal anatomical structure
Helmy et al. Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection
EP4397656A3 (en) Hdac6 inhibitors and imaging agents
PL3783068T3 (pl) Ziarnista sadza przewodząca i sposób jej otrzymywania
EP4433960A4 (en) SYSTEMS AND METHODS FOR READING SUPERCONDUCTIVE FLOW QUANTUM BITS
NZ721882A (en) Selection of agents modulating gastrointestinal pain
GB202007217D0 (en) Artificial intelligence and augmented reality system and method
KR102590387B9 (ko) 인공지능 기반의 근육 초음파를 이용한 수근관 증후군 진단 시스템 및 방법
Mainali et al. Evaluation of antimicrobial resistance profiles of Salmonella isolates from broiler chickens at slaughter in Alberta, Canada
Luque et al. Salmonella Indiana as a cause of abortion in ewes: Genetic diversity and resistance patterns
SG11202007983YA (en) Image mapping player and pixel debugging method
EP4306959A3 (en) Method for determining deterioration of a disease condition of a parkinson s disease patient
EP3729577A4 (en) INSERT BLOCK AND SEALING SYSTEM WITH THIS INSERT BLOCK
Hu Microencapsulation of Lactobacillus paracasei with a polysaccharide extraced from Ficus awkeotsang Makino
RU2015155841A (ru) Способ коррекции недостаточности питания у больных, получающих заместительную почечную терапию, с адекватным потреблением основных нутриентов
Shust et al. Analysis of quantitative and qualitative composition of some probiotics as dependent on the production of the preparation
Hall et al. Re: Elliott CS, Comiter CV. The effect of angiotensin inhibition on urinary incontinence: data from the National Health and Nutrition Examination Survey (2001-2008). Neurourol Urodyn 2014; 33: 1178-81
FI3528801T3 (fi) Beeta-hydroksi-beeta-metyylibutyraatin (hmb) ja probioottien koostumuksia ja menetelmiä niiden käyttämiseksi